Red Violet director granted 2,088 RSUs

Red Violet, Inc. director William Paul Livek received an equity grant of 2,088 restricted stock units (RSUs) on June 4, 2026.

Rhea-AI Filing Summary

Red Violet, Inc. director William Paul Livek received an equity grant of 2,088 restricted stock units (RSUs) on June 4, 2026. These RSUs convert into common stock on a one-for-one basis and vest on the earlier of one year from grant or the 2027 annual stockholder meeting, with potential accelerated vesting in certain cases.

After this grant, Livek holds 20,733 shares and RSUs in total, including several prior RSU awards with scheduled vesting dates through December 1, 2028 and 4,517 vested RSUs for which share delivery has been deferred until separation from service, death, or disability.

Insider Trade Summary

Grant/Award: 2,088 shares

Grant/Award 1 txn

Insider LIVEK WILLIAM PAUL

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,088	$0.00	$0.00

Holdings After Transaction: Common Stock — 20,733 shares (Direct)

Footnotes (6)

1. F1. On June 4, 2026, the reporting person received a grant of 2,088 restricted stock units ("RSUs"), convertible into common stock of the issuer on a one-for-one basis, which vests on the earlier of one year from the date of grant or the 2027 annual meeting of stockholders, subject to accelerated vesting under certain conditions.
2. F2. Includes 1,383 RSUs originally granted on January 5, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests on December 1, 2026.
3. F3. Includes 2,506 RSUs originally granted on November 4, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances.
4. F4. Includes 1,484 RSUs originally granted on March 4, 2025, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances.
5. F5. Includes 4,517 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability.
6. F6. Includes 3,755 RSUs originally granted on December 19, 2025, convertible into common stock of the issuer on a one-for-one basis, which vests in three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain circumstances.

Key Figures

New RSU grant: 2,088 RSUs Post-transaction holdings: 20,733 shares/RSUs January 5, 2024 RSUs: 1,383 RSUs +4 more

7 metrics

New RSU grant 2,088 RSUs Granted June 4, 2026 to director William Paul Livek

Post-transaction holdings 20,733 shares/RSUs Total common stock and RSUs following the grant

January 5, 2024 RSUs 1,383 RSUs Vest on December 1, 2026

November 4, 2024 RSUs 2,506 RSUs Vest in equal installments on November 1, 2026 and November 1, 2027

March 4, 2025 RSUs 1,484 RSUs Vest in equal installments on November 1, 2026 and November 1, 2027

Deferred vested RSUs 4,517 RSUs Vested, delivery deferred until separation, death, or disability

December 19, 2025 RSUs 3,755 RSUs Vest in three equal installments on December 1, 2026, 2027, and 2028

Key Terms

restricted stock units, RSUs, accelerated vesting, annual meeting of stockholders, +1 more

5 terms

restricted stock units financial

"received a grant of 2,088 restricted stock units ("RSUs"), convertible into common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"Includes 4,517 vested RSUs in which the reporting person has elected to defer delivery"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

accelerated vesting financial

"subject to accelerated vesting under certain conditions"

A contract feature that makes stock awards, options, or restricted shares become owned or exercisable earlier than the original schedule. It shortens or cancels the waiting period so recipients can sell, transfer, or exercise their equity sooner — think of a timed lock that is unlocked ahead of schedule. It matters to investors because it changes when shares enter the market, who controls them, and how much dilution or ownership concentration happens.

annual meeting of stockholders financial

"vests on the earlier of one year from the date of grant or the 2027 annual meeting of stockholders"

defer delivery financial

"elected to defer delivery until the reporting person's separation of service from the issuer or death or disability"

FAQ

What did Red Violet (RDVT) director William Paul Livek receive in this Form 4 filing?

Director William Paul Livek received a grant of 2,088 restricted stock units, each convertible into one Red Violet common share. The grant was made on June 4, 2026 as equity compensation, with no cash purchase involved.

When do the new 2,088 RSUs for Red Violet (RDVT) director William Livek vest?

The 2,088 RSUs vest on the earlier of one year from the June 4, 2026 grant date or the 2027 annual meeting of stockholders. Vesting may accelerate under certain conditions described in the award terms.

How many Red Violet (RDVT) shares and RSUs does William Livek hold after this transaction?

Following the grant, William Livek holds a total of 20,733 Red Violet common shares and RSUs. This total includes the new 2,088-unit award plus several earlier RSU grants and deferred vested RSUs.

What other RSU awards are outstanding for Red Violet (RDVT) director William Livek?

Outstanding awards include 1,383 RSUs vesting December 1, 2026; 2,506 RSUs vesting in equal parts on November 1, 2026 and 2027; 1,484 RSUs vesting in equal parts on November 1, 2026 and 2027; and 3,755 RSUs vesting over three dates through December 1, 2028.

What does it mean that some Red Violet (RDVT) RSUs are deferred until separation from service?

Livek has 4,517 vested RSUs where he has elected to defer share delivery until separation from Red Violet, death, or disability. The units are vested but the actual common shares will be issued only upon those triggering events.

Are the Red Violet (RDVT) RSUs granted to William Livek subject to accelerated vesting?

Yes. The new 2,088 RSUs, and certain earlier grants, are described as subject to accelerated vesting under specified circumstances, which typically relate to events like termination conditions, though exact triggers are defined in the underlying award agreements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 05:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LIVEK WILLIAM PAUL

(Last) (First) (Middle)

C/O RED VIOLET, INC.

2650 N. MILITARY TRAIL, SUITE 300

(Street)

BOCA RATON FLORIDA 33431

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Red Violet, Inc. [ RDVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		2,088(1)	A	(1)	20,733(1)(2)(3)(4)(5)(6)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On June 4, 2026, the reporting person received a grant of 2,088 restricted stock units ("RSUs"), convertible into common stock of the issuer on a one-for-one basis, which vests on the earlier of one year from the date of grant or the 2027 annual meeting of stockholders, subject to accelerated vesting under certain conditions.

2. Includes 1,383 RSUs originally granted on January 5, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests on December 1, 2026.

3. Includes 2,506 RSUs originally granted on November 4, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances.

4. Includes 1,484 RSUs originally granted on March 4, 2025, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances.

5. Includes 4,517 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability.

6. Includes 3,755 RSUs originally granted on December 19, 2025, convertible into common stock of the issuer on a one-for-one basis, which vests in three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain circumstances.

Remarks:

Includes 3,755 RSUs originally granted on December 19, 2025, convertible into common stock of the issuer on a one-for-one basis, which vests in three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain circumstances.

	/s/ William Livek	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)